• American College of Obstetricians and Gynecologists. Committee Opinion no. 545. 2012. Noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol. 120: 15321534.
  • Ashoor G, Syngelaki A, Poon LC, Rezende JC, Nicolaides KH. 2013. Fetal fraction in maternal plasma cell-free DNA at 11–13 weeks' gestation: relation to maternal and fetal characteristics. Ultrasound Obstet Gynecol. 41: 2632.
  • Benn P, Borrell A, Cuckle H, Dugoff L, Gross S, Johnson JA, Maymon R, Odibo A, Schielen P, Spencer K, Wright D, Yaron Y. 2012. Prenatal detection of down syndrome using massively parallel sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 2011. Prenat Diagn. 32: 12.
  • Brar H, Wang E, Struble C, Musci TJ, Norton ME. 2013. The fetal fraction of cell-free DNA in maternal plasma is not affected by a priori risk of fetal trisomy. J Matern Fetal Neonatal Med. 26: 143145.
  • Devers PL, Cronister A, Ormond KE, Facio F, Brasington C, Flodman P. Adopted February 18, 2012. Noninvasive prenatal testing/noninvasive prenatal diagnosis: the position of the national society of genetic counselors. Available online at
  • Kitzman JO, Snyder MW, Ventura M, Lewis AP, Qiu R, Simmons LE, Gammill HS, Rubens CE, Santillan DA, Murray JC, Tabor HK, Bamshad MJ, Eichler EE, Shendure J. 2012. Noninvasive whole-genome sequencing of a human fetus. Sci Transl Med. 4: 137ra76.
  • Wilson KL, Czerwinski JL, Hoskovec JM, Noblin SJ, Sullivan CM, Harbison A, Campion MW, Devary K, Devers P, Singletary CN. 2012. NSGC practice guideline: prenatal screening and diagnostic testing options for chromosome aneuploidy. J Genet Couns. Epub Epahead of print. DOI 10.1007/s10897-012-9545-3.